Min-Shan Chen

7.8k total citations · 2 hit papers
58 papers, 5.3k citations indexed

About

Min-Shan Chen is a scholar working on Hepatology, Oncology and Surgery. According to data from OpenAlex, Min-Shan Chen has authored 58 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Hepatology, 27 papers in Oncology and 19 papers in Surgery. Recurrent topics in Min-Shan Chen's work include Hepatocellular Carcinoma Treatment and Prognosis (38 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (18 papers) and Liver Disease Diagnosis and Treatment (9 papers). Min-Shan Chen is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (38 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (18 papers) and Liver Disease Diagnosis and Treatment (9 papers). Min-Shan Chen collaborates with scholars based in China, Hong Kong and United States. Min-Shan Chen's co-authors include Rong Guo, Xiao-Jun Lin, Wan Yee Lau, Ya-Qi Zhang, Hui-Hong Liang, Jin-Qing Li, Yaojun Zhang, Ming Shi, Yun Zheng and Zhenwei Peng and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Hepatology.

In The Last Decade

Min-Shan Chen

58 papers receiving 5.2k citations

Hit Papers

A Prospective Randomized Trial Comparing Percutaneous Loc... 2006 2026 2012 2019 2006 2012 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A Prospective Randomized Trial Comparing Percutaneous Local Ablative Therapy and Partial Hepatectomy for Small Hepatocellular Carcinoma
    2006 1.0k citations Min-Shan Chen, Jin-Qing Li et al. Annals of Surgery profile →
  2. Radiofrequency Ablation With or Without Transcatheter Arterial Chemoembolization in the Treatment of Hepatocellular Carcinoma: A Prospective Randomized Trial
    2012 369 citations Zhenwei Peng, Yaojun Zhang et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Min-Shan Chen China 32 3.3k 1.9k 1.4k 1.3k 896 58 5.3k
Minshan Chen China 35 3.1k 0.9× 1.4k 0.7× 1.3k 1.0× 949 0.7× 1.0k 1.2× 190 5.1k
Boheng Zhang China 33 2.2k 0.6× 1.6k 0.8× 1.1k 0.8× 785 0.6× 1.0k 1.2× 83 4.1k
Baogang Peng China 32 1.7k 0.5× 880 0.5× 1.2k 0.9× 810 0.6× 875 1.0× 103 3.6k
Shinichi Aishima Japan 40 1.8k 0.5× 1.5k 0.8× 2.2k 1.6× 2.1k 1.6× 1.1k 1.2× 167 5.1k
Susumu Yamasaki Japan 31 2.7k 0.8× 1.4k 0.7× 1.6k 1.2× 2.2k 1.7× 497 0.6× 66 4.7k
Alessandro Granito Italy 49 2.9k 0.9× 2.6k 1.4× 544 0.4× 1.3k 1.0× 375 0.4× 149 4.8k
Aiwu Ruth He United States 32 1.4k 0.4× 609 0.3× 2.2k 1.6× 594 0.5× 935 1.0× 187 4.5k
Zhao‐Chong Zeng China 37 1.4k 0.4× 625 0.3× 1.5k 1.1× 1.1k 0.8× 1.4k 1.6× 198 5.1k
Shuntaro Obi Japan 28 3.5k 1.1× 2.1k 1.1× 619 0.4× 987 0.8× 572 0.6× 81 4.3k
Wen‐Ming Cong China 34 1.2k 0.4× 655 0.3× 773 0.6× 718 0.6× 1.1k 1.2× 135 3.4k

Countries citing papers authored by Min-Shan Chen

Since Specialization
Citations

This map shows the geographic impact of Min-Shan Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Min-Shan Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Min-Shan Chen more than expected).

Fields of papers citing papers by Min-Shan Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Min-Shan Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Min-Shan Chen. The network helps show where Min-Shan Chen may publish in the future.

Co-authorship network of co-authors of Min-Shan Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Min-Shan Chen. A scholar is included among the top collaborators of Min-Shan Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Min-Shan Chen. Min-Shan Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Xuyan, Wei Shi, Yingzhe Wang, et al.. (2024). Pericancerous cross-presentation to cytotoxic T lymphocytes impairs immunotherapeutic efficacy in hepatocellular carcinoma. Cancer Cell. 42(12). 2082–2097.e10. 16 indexed citations
2.
3.
Zhang, Yong‐Fa, Jie Zhou, Wei Wei, et al.. (2016). Intermediate-stage hepatocellular carcinoma treated with hepatic resection: the NSP score as an aid to decision-making. British Journal of Cancer. 115(9). 1039–1047. 19 indexed citations
4.
Xu, Li, Jun Wang, Yuhree Kim, et al.. (2015). A randomized controlled trial on patients with or without adjuvant autologous cytokine-induced killer cells after curative resection for hepatocellular carcinoma. OncoImmunology. 5(3). e1083671–e1083671. 54 indexed citations
5.
6.
7.
Zhang, Yaojun, et al.. (2013). Radiofrequency Ablation Does Not Induce the Significant Increase of CD4+CD25+Foxp3+ Regulatory T Cells Compared with Surgical Resection in Hepal-6 Tumor Model. Archivum Immunologiae et Therapiae Experimentalis. 61(4). 333–340. 10 indexed citations
8.
Peng, Zhenwei, Yaojun Zhang, Min-Shan Chen, et al.. (2012). Radiofrequency Ablation With or Without Transcatheter Arterial Chemoembolization in the Treatment of Hepatocellular Carcinoma: A Prospective Randomized Trial. Journal of Clinical Oncology. 31(4). 426–432. 369 indexed citations breakdown →
9.
Peng, Zhenwei, Xiao-Jun Lin, Yaojun Zhang, et al.. (2012). Radiofrequency Ablation versus Hepatic Resection for the Treatment of Hepatocellular Carcinomas 2 cm or Smaller: A Retrospective Comparative Study. Radiology. 262(3). 1022–1033. 169 indexed citations
10.
Shi, Ming, Ligong Lu, Rong Guo, et al.. (2012). Roles Played by Chemolipiodolization and Embolization in Chemoembolization for Hepatocellular Carcinoma: Single-Blind, Randomized Trial. JNCI Journal of the National Cancer Institute. 105(1). 59–68. 60 indexed citations
11.
Peng, Zhenwei, Yaojun Zhang, Hui-Hong Liang, et al.. (2011). Recurrent Hepatocellular Carcinoma Treated with Sequential Transcatheter Arterial Chemoembolization and RF Ablation versus RF Ablation Alone: A Prospective Randomized Trial. Radiology. 262(2). 689–700. 166 indexed citations
12.
Zhao, Jing-Jing, Ke Pan, Xiao Hai Li, et al.. (2011). Identification of LZAP as a New Candidate Tumor Suppressor in Hepatocellular Carcinoma. PLoS ONE. 6(10). e26608–e26608. 31 indexed citations
13.
Luo, Jun, et al.. (2011). Blood Neutrophil-to-lymphocyte Ratio Predicts Survival in Patients with Unresectable Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization. Journal of Vascular and Interventional Radiology. 22(5). 702–709. 97 indexed citations
14.
Pan, Ke, Min-Shan Chen, Qi-Jing Wang, et al.. (2010). Dendritic cells-mediated CTLs targeting hepatocellular carcinoma stem cells. Cancer Biology & Therapy. 10(4). 368–375. 34 indexed citations
15.
Liang, Hui-Hong, Zhenwei Peng, Min-Shan Chen, et al.. (2010). Efficacy of combining temperature- and power-controlled radiofrequency ablation for malignant liver tumors. Chinese Journal of Cancer. 29(4). 408–412. 6 indexed citations
16.
Zhang, Jing‐Ping, Jing Yan, Jing Xu, et al.. (2009). Increased intratumoral IL-17-producing cells correlate with poor survival in hepatocellular carcinoma patients. Journal of Hepatology. 50(5). 980–989. 438 indexed citations
17.
Liang, Hui-Hong, Min-Shan Chen, Zhenwei Peng, et al.. (2008). Percutaneous Radiofrequency Ablation Versus Repeat Hepatectomy for Recurrent Hepatocellular Carcinoma: A Retrospective Study. Annals of Surgical Oncology. 15(12). 3484–3493. 98 indexed citations
18.
Zhang, Yaojun, Hui-Hong Liang, Min-Shan Chen, et al.. (2007). Hepatocellular Carcinoma Treated with Radiofrequency Ablation with or without Ethanol Injection: A Prospective Randomized Trial. Radiology. 244(2). 599–607. 115 indexed citations
19.
Peng, Zhenwei, Yaojun Zhang, Min-Shan Chen, et al.. (2007). Risk factors of survival after percutaneous radiofrequency ablation of hepatocellular carcinoma. Surgical Oncology. 17(1). 23–31. 30 indexed citations
20.
Shi, Ming, Rong Guo, Xiao-Jun Lin, et al.. (2006). Partial Hepatectomy With Wide Versus Narrow Resection Margin for Solitary Hepatocellular Carcinoma. Annals of Surgery. 245(1). 36–43. 378 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Minshan Chen Breakdown of academic impact, for papers by Boheng Zhang Breakdown of academic impact, for papers by Baogang Peng Breakdown of academic impact, for papers by Shinichi Aishima Breakdown of academic impact, for papers by Susumu Yamasaki Breakdown of academic impact, for papers by Alessandro Granito Breakdown of academic impact, for papers by Aiwu Ruth He Breakdown of academic impact, for papers by Zhao‐Chong Zeng Breakdown of academic impact, for papers by Shuntaro Obi Breakdown of academic impact, for papers by Wen‐Ming Cong
Rankless by CCL
2026